Article
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.
European journal of clinical pharmacology - 1 Aug 2006
Joerger M, Bosch T M, Doodeman V D, Beijnen J H, Smits P H M, Schellens J H M
Abstract excerpt
INTRODUCTION: Deoxycytidine kinase (DCK) is the rate-limiting enzyme of the intracellular phosphorylation of nucleoside anticancer drugs, including gemcitabine and beta-arabinofuranosylcytosine, to their active triphosphates. This study was performed to assess the occurrence and frequency of DCK polymorphisms in a predominantly Caucasian population and to choose candidate polymorphisms for subsequent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
